Description of Sign-and-symptom Associations at Acromegaly Diagnosis.

The purpose of this study is to describe most characteristic association of signs and symptoms present at the time of acromegaly diagnosis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acromegaly Bone Diseases Bone Diseases, Endocrine Brain Diseases Central Nervous System Diseases Endocrine System Diseases Hyperpituitarism Hypothalamic Diseases Musculoskeletal Diseases Nervous System Diseases Pituitary Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Sud, Amiens, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult patient (greater than or equal to 18 years old)
Patient with acromegaly, diagnosed for less than 5 years

Exclusion criteria

Patient who have objected to the collection of his/her data

Treatment and study plan

Primary outcomes

Description of the most characteristic sign-and-symptom associations of acromegaly, collected by a patient questionnaire.

Time frame: At the time of patient diagnosis, up to 3 months

Secondary outcomes

Description of demographic and clinical characteristics of patients with acromegaly, collected by a patient questionnaire.

Time frame: At the time of patient diagnosis, up to 3 months

Sponsors and collaborators

Lead sponsor

Ipsen

Industry

Registry information

Acronym: ACRO-POLIS

Important dates

Study start: 2013
Primary completion: 2014
Study completion: 2014
First posted: Dec 16, 2013
Registry last updated: Aug 5, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed